Transipeg forte, Pulver zur Herstellung einer Lösung zum Einnehmen - 30 Sachet(s) Swissmedic Key 53282105 Registration Holder CPS Cito Pharma Services GmbH Name Transipeg forte, Pulver zur Herstellung einer Lösung zum Einnehmen Date of registration 14.02.1996 Introduction of Sequence 09.08.1999 ATC-Classification Macrogol, Combinations (A06AD65) Revision date 31.01.2006 WHO WHO-DDD Valid until Index Therapeuticus (BSV) 04.08.11. Show package size 30 Sachet(s) Index Therapeuticus (Swissmedic) 04.08.11. Description Swissmedic categorie. D SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 9.81 Limitation Yes Limitation text
Deductible 10 % Consumer price 18.10 Feedback FB GTIN 7680532821057 Medication Code Synthetika Pharmacode 2188166 Disponibility ●
Composition macrogolum 3350 5900 mg, natrii chloridum 146 mg, natrii sulfas anhydricus 568 mg, kalii chloridum 75 mg, natrii hydrogenocarbonas 168 mg, aspartamum 7.5 mg, acesulfamum kalicum, aromatica (Zitrone) cum saccharum 38.8 mg, ad pulverem, pro charta corresp. natrium 287.4 mg. Packungsbestandteile Galenic Form Pulver zur Herstellung einer Lösung zum Einnehmen Excipiens Active Agent Dose Potassium Chloride 75 mg Macrogolum 3350 5900 mg Sodium Chloride 146 mg Sodium Hydrogen Carbonate 168 mg Sodium Sulfate Anhydrate 568 mg
BAG: Active Agent Dose Potassium Chloride 75 mg Macrogolum 3350 5.9 g Sodium Chloride 146 mg Sodium Hydrogen Carbonate 168 mg Sodium Sulfate Anhydrate 568 mg
Inactive agents Dose Acesulfamum Kalicum Aromatica (Zitrone) cum Saccharum 38.8 mg Aspartame 7.5 mg
Source Data was imported : 04.03.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
